Apontis Pharma AG (ETR:APPH)
Germany · Delayed Price · Currency is EUR 10.85
+0.05 (0.46%)
Aug 1, 2025, 5:36 PM CET
Apontis Pharma AG Market Cap
Apontis Pharma AG has a market cap or net worth of €90.38 million as of August 1, 2025. Its market cap has increased by 23.30% in one year.
Market Cap
90.38M
Enterprise Value
74.93M
Revenue
48.47M
Ranking
n/a
PE Ratio
119.94
Stock Price
€10.85
Market Cap Chart
Since May 11, 2021, Apontis Pharma AG's market cap has decreased from 159.38M to 90.38M, a decrease of -43.29%. That is a compound annual growth rate of -12.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 90.38M | 7.96% |
| Dec 30, 2024 | 83.72M | 111.58% |
| Dec 29, 2023 | 39.57M | -43.23% |
| Dec 30, 2022 | 69.70M | -59.00% |
| Dec 30, 2021 | 170.00M | 6.67% |
| May 11, 2021 | 159.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.71B |
| Merck KGaA | 46.59B |
| Bayer Aktiengesellschaft | 27.63B |
| Fresenius SE & Co. KGaA | 23.64B |
| Fresenius Medical Care AG | 13.05B |
| Sartorius Aktiengesellschaft | 11.85B |
| Fielmann Group AG | 4.65B |
| Carl Zeiss Meditec AG | 4.26B |